Pui Wang

ORCID: 0000-0003-0745-1130
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunotherapy and Immune Responses
  • vaccines and immunoinformatics approaches
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 Research
  • Immune Response and Inflammation
  • Viral gastroenteritis research and epidemiology
  • Immune Cell Function and Interaction

University of Hong Kong
2022-2025

HKU-Pasteur Research Pole
2025

Chinese University of Hong Kong
2024

Abstract Current available vaccines for COVID-19 are effective in reducing severe diseases and deaths caused by SARS-CoV-2 infection but less optimal preventing infection. Next-generation which able to induce mucosal immunity the upper respiratory prevent or reduce infections highly transmissible variants of urgently needed. We have developed an intranasal vaccine candidate based on a live attenuated influenza virus (LAIV) with deleted NS1 gene that encodes cell surface expression...

10.1038/s41467-023-37697-1 article EN cc-by Nature Communications 2023-04-12

Abstract Memory T cells play a key role in immune protection against cancer. Vaccine-induced tissue-resident memory (TRM) the lung have been shown to protect metastasis. Identifying source of TRM can help improve strategies, preventing tumor Here, we found that prime-boost vaccination approach using intramuscular DNA vaccine priming, followed by intranasal live-attenuated influenza-vectored (LAIV) boosting induced higher frequencies CD8+ compared with other regimens. cells, but not...

10.1158/0008-5472.can-23-3257 article EN cc-by-nc-nd Cancer Research 2024-07-18

<div>Abstract<p>Memory T cells play a key role in immune protection against cancer. Vaccine-induced tissue-resident memory (T<sub>RM</sub>) the lung have been shown to protect metastasis. Identifying source of T<sub>RM</sub> can help improve strategies, preventing tumor Here, we found that prime-boost vaccination approach using intramuscular DNA vaccine priming, followed by intranasal live-attenuated influenza-vectored (LAIV) boosting induced higher...

10.1158/0008-5472.c.7474557 preprint EN 2024-10-01

Abstract We have developed an intranasal vaccine candidate based on a live attenuated influenza virus (LAIV) with deleted NS1 gene that encodes cell surface expression of the receptor-binding-domain (RBD) SARS-CoV-2 spike protein, designated DelNS1-RBD4N-DAF. Immune responses and protection against challenge following administration DelNS1-RBD4N-DAF vaccines were analyzed in mice compared intramuscular injection BioNTech BNT162b2 mRNA hamsters. LAIVs induced high levels neutralizing...

10.21203/rs.3.rs-1880060/v1 preprint EN cc-by Research Square (Research Square) 2022-07-26
Coming Soon ...